Dr. Louise Sarup is an associate director, Business Development and Licensing at Weill Cornell Medicine. Prior to joining CTL, Dr. Sarup was based in Singapore where she was head of business development and licensing for D3 (now EDDC), a drug discovery and development group based at A*STAR. Some of her previous roles include corporate development manager at S*BIO Pte Ltd. (Singapore), an oncology-focused biotech, vice president of business development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets and director (licensing) at Cytiva, a global life science company. Dr. Sarup has also worked for leading life science and health care communication agencies and UCL Business, the commercialization company of University College London.
Dr. Sarup earned her Ph.D. in Biochemical Engineering from University College London, MSc in Biotechnology from Nottingham Trent University, and B.Eng (Hons) in Chemical and Process Engineering from Newcastle University.